Table 3 Prophylactic treatment after detoxification programme
From: Drug-dependence behaviour and outcome of medication-overuse headache after treatment
Total (n = 120) | R-group (n = 68) | NR-group (n = 52) | Test statistics | p value | |
|---|---|---|---|---|---|
Tricyclic antidepressants | 24 (20.0 %) | 18 (26.5 %) | 6 (11.5 %) | χ2 = 4.10 | 0.0427 |
Beta-blockers | 7 (5.8 %) | 4 (5.9 %) | 3 (5.8 %) | χ2 = 0.00 | 0.9791 |
Antiepileptics | 50 (41.7 %) | 23 (33.8 %) | 27 (54.0 %) | χ2 = 3.97 | 0.0462 |
SSRIs | 5 (4.2 %) | 5 (7.3 %) | 0 (0 %) | χ2 = 3.99 | 0.0683 |
Combination of prophylactic treatments | 29 (24.2 %) | 14 (20.6 %) | 15 (28.8 %) | χ2 = 1.09 | 0.2950 |